Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640334-21-000383
Filing Date
2021-02-17
Accepted
2021-02-17 17:11:43
Documents
1
Period of Report
2021-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4355
  Complete submission text file 0001640334-21-000383.txt   5921
Mailing Address 888 PROSPECT STREET, SUITE 210 LA JOLLA CA 92037
Business Address 888 PROSPECT STREET, SUITE 210 LA JOLLA CA 92037 760-943-1689
ARTELO BIOSCIENCES, INC. (Issuer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARTELO BIOSCIENCES, INC. 888 PROSPECT ST, SUITE 210 LA JOLLA CA 92037
Business Address
Blayney Douglas (Reporting) CIK: 0001772396 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38951 | Film No.: 21646016